Dr. Alberto Giuseppe Distefano
M.D. | Neuro-ophthalmology Specialist | 15+ years Exp
Medicare Enrolled 17 E 102nd St Fl 8, New York
New York, 10029-5204
212-241-0939 Maps & DirectionsDr. Alberto Giuseppe Distefano is a New York, New York based Neuro-ophthalmology Specialist with 15 years of experience in Neuro-ophthalmology. He completed his graduation from New York Medical College in 2011. He is also affiliated with hospitals like Boston Medical Center and Signature Healthcare Brockton Hospital. He accepts the Medicare-approved amount. Patients will not be billed for any more than the Medicare deductible and coinsurance. Active license number of Dr. Alberto Giuseppe Distefano is 269827 for Ophthalmology in New York.
Dr. Alberto Giuseppe Distefano evaluates, treats, and studies disorders of the eye, orbit and nervous system having to do with interactions of the visual motor and visual sensory systems with the central nervous system. Neuro-ophthalmologists manage patients with complex and severe neuro-ophthalmological disorders.
Complete Profile:
Dr. Alberto Giuseppe Distefano speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
| Specialization: | Neuro-ophthalmology |
| Credentials: | M.D. |
| Experience: | 15+ years |
| Medical School Attended: | New York Medical College |
| Graduation Year: | 2011 |
| Gender: | Male |
| Accepts Medicare Assignment: | Yes |
| Practice Address: | 17 E 102nd St Fl 8, New York,
New York, 10029-5204 |
| Phone: | 212-241-0939 |
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
| PAC ID: | 4385951227 |
| Enrollment ID: | I20180627002650 |
| NPI Number: | 1558660340 |
| NPI Enumeration Date: | 20 Mar, 2011 |
| NPI Last Update On: | 07 Apr, 2023 |
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Alberto Giuseppe Distefano are as mentioned below.
| License Number | Specialization | State | Status | |
| 269827 | Ophthalmology | New York | Primary | |
| 269827 | Neuro-ophthalmology | New York | Secondary | |
| 269827 | Ophthalmic Plastic and Reconstructive Surgery | New York | Secondary | |
Hospital Affiliation:
Doctors can be affiliated to many hospitals whom they worked with in the past or are presently working with. One surgeon can be affiliated to four to five hospitals at a time.
| Hospital Name (CCN) | State | Hospital Type |
| Boston Medical Center (220031) | Boston, MA | Acute Care Hospital |
| Signature Healthcare Brockton Hospital (220052) | Brockton, MA | Acute Care Hospital |
Group Practice:
Group practices are run by a group of physicians who share their premises and other resources. Following list states all the group name
with which Dr. Alberto Giuseppe Distefano has association with along with the number of members in that group.
| Organization Name (Group PAC ID) | Members |
| Boston University Eye Associates Inc (4789571225) | 24 |
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
| Address: | 310 E 14th St Fl 3,
New York, New York |
| Zip: | 10003-4284 |
| Phone Number: | 212-979-4500 |
Patients can reach Dr. Alberto Giuseppe Distefano at
17 E 102nd St Fl 8, New York, New York or can
call to book an appointment on 212-241-0939.
Comments/ Reviews:
Patients can read all the reviews posted for Dr. Alberto Giuseppe Distefano below. You may also share your own experience like the quality of treatment, behavior, and overall care provided by Dr. Alberto Giuseppe Distefano. It will help others make informed decisions.
** Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 08 June, 2026.